Cyclophosphamide
NDC 10019-955, cyclophosphamide, injection, powder, for solution, from Baxter Healthcare Company.
- Product NDC
- 10019-955
- Status
- Listed
- Labeler
- Baxter Healthcare Company
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS, ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040745
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10019-955 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYCLOPHOSPHAMIDE500 mg/25mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10019-955-01 | 10019095501 | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-955-01) / 25 mL in 1 VIAL, SINGLE-DOSE (10019-955-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/591d9955-3d9c-4cdc-a308-2f1288376b9fMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=10019-955
Use it
Look up 10019-955 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10019-955 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10019-955. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.